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Duchenne muscular dystrophy is a hereditary disorder characterized by progressive muscle weakness and 
contracture, and special care during anesthesia is needed in these patients. Because inhalational anesthetics and 
succinylcholine can cause fatal results, intravenous anesthetics are commonly used. However, monitorings for the 
pediatric population are not otherwise specified. We report our experience of a 6 year-old boy that underwent muscle 
biopsy suspicious of muscle dystrophy under general anesthesia. The patient received midazolam, fentanyl, propofol 
and a small dose of rocuronium. He was monitored with bispectral index (BIS), acceleromyography (TOF). At the end 
of surgery, recovery of TOF ratio to 90% was evaluated, followed by injection of pyridostigmine and glycopyrrolate. 
When reversal of neuromuscular block was confirmed quantitatively and clinically, the patient was extubated and he 
experienced no complication. (Korean J Anesthesiol 2011; 61: 159-161)
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     Anesthesia for children with Duchenne muscular dystrophy 
(DMD) should take into account rhabdomyolysis, malignant 
hyperthermia-like reaction and cardiac arrest. Intravenous 
and non-depolarizing muscle relaxants are commonly used in 
children. Inhalational anesthetics and succinylcholine can lead 
to complications. However, monitoring for pediatric patients 
are not otherwise specified.
     Intravenous anesthesia with target-controlled infusion of 
propofol and remifentanil are limited by body weight and 
age. For young children, intravenous anesthesia is guided by 
vital signs, as neuromuscular monitoring for the pediatric 
population is not well established. We herein report our 
experience performing anesthetic monitoring on a child with 
suspected DMD. 
Case Report 
     A 6-year-old, 19 kg, child was admitted to our hospital with 
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symptoms of proximal muscle weakness and a one-month 
history of difficulty climbing steps. He was planned to undergo 
muscle biopsy under the suspicion of DMD. Preoperative 
laboratory tests were abnormal: aspartate transaminase (AST) 
560 IU/L, alanine transaminase (ALT) 773 IU/L, alkaline 
phosphatase 352 IU/L, lactate dehydrogenase (LDH) 4,280 IU/L, 
creatinine phosphokinase (CPK) 32,730 IU/L. His electrolytes, 
urine exam, electrocardiography and chest radiography were 
unremarkable. Preoperative echocardiography and pulmonary 
function test were considered to be unnecessary by the 
attending pediatrician.
    The patient received no premedication. Upon arrival in the 
operating room, standard monitoring, including EKG, pulse 
oximetry, end-tidal capnography, transesophageal temperature 
probe, bispectral index (BIS vista
TM, Aspect Medical Systems, 
The Netherlands) and Train-of-four monitor (TOF watch
TM, 
Organon, Ireland) were applied. 
    Anesthesia was induced with intravenous midazolam 1 
mg, fentanyl 25 μg, and continuous infusion of propofol. 
Rocuronium bromide 6 mg was administered to facilitate 
orotracheal intubation. BIS 40-65 was maintained and 30 mA 
at 2 Hz TOF was monitored during anesthesia. Anesthesia was 
maintained with nitrous oxide 50% in oxygen and end-tidal 
CO2 was maintained at 30-35 mmHg. Intraoperative vital signs 
were as follows: blood pressure: 92-115/50-60 mmHg, heart 
rate: 100-107 bpm, oxygen saturation: 100%, and temperature: 
36.3
oC. Propofol was stopped at the end of surgery. Following 
recovery of TOF to 90%, neuromuscular blockade was reversed 
with pyridostigmine 4 mg and glycopyrrolate 0.16 mg. The 
patient opened his eyes spontaneously, responded to verbal 
command, and was able to lift his head. He was subsequently 
extubated. Total anesthetic time was 45 min. In the recovery 
room, muscular tone was re-evaluated but we did not check the 
TOF. Biopsy result confirmed Duchenne muscular dystrophy. 
Discussion
    DMD is the most common muscular dystrophy. It is a X-linked 
disease caused by mutations in the dystrophins gene. The 
disease is characterized by severe proximal muscle weakness, 
progressive degeneration, and fatty infiltration of the muscles. 
Serum creatine kinase is increased at the early stages, as do 
liver enzymes. The clinical course of DMD is severe and there 
is no therapy available. Progressive and severe muscle atrophy 
and weakness cause loss of ability to ambulate by the teenager. 
DMD affects the muscles of respiration and is associated with 
dilated cardiomyopathy, which often leads to death secondary 
to cardiopulmonary causes.
    Patients with DMD are vulnerable to the adverse physiologic 
effects of general anesthesia and procedural sedation. They 
are at increased risk of rhabdomyolysis, life-threatening 
hyperkalemia, malignant hyperthermia-like reaction and heart 
failure when they are exposed to inhalational anesthetics and 
succinylcholine. Intravenous anesthetics such as propofol, 
ketamine and dexmedetomidine are reasonable alternatives 
and commonly used at variable doses [1-3]. However, there is 
no risk-free choice and a lack of prospective clinical studies to 
determine the safest anesthetic technique for DMD patients. In 
order to decrease risks such as rhabdomyolysis, we used small 
doses of midazolam and propofol under BIS monitoring. 
    The responsiveness of DMD patients administered with 
standard dosage of nondepolarizing neuromuscular blocking 
agent differs from that in normal patients. Delayed onset of 
blockade in DMD following administration of standard dose 
rocuronium, and the prolonged recovery from rocuronium-
induced blockade necessitate the need for careful assessment 
of neuromuscular function. If rocuronium is administered in 
DMD, assessment of complete neuromuscular recovery (TOF 
ratio = 0.9) by quantitative measurement, such as accelero-
myography, is mandatory. 
    However, use of reduced electrical current for pediatric TOF 
monitoring may be necessary [4-6]. Using succinylcholine 
for the setup and stabilization of neuromuscular monitoring 
in children has been reported [7]. However, this method is 
not appropriate for DMD. We used 30 mA at 2 Hz TOF during 
surgery. TOF was not established for the child in the recovery 
room, and we monitored the muscle strength clinically. 
    Anesthetic induction dosage of propofol decreases with 
increasing patient age. As such, bolus dose used for children 
are much higher than that of adult. According to the pharmaco-
kinetics of child, initial loading dose and maintenance dose 
should be given more than adult [8,9]. Target-controlled in-
fusion (TCI) system of propofol (Diprifusor
TM, Fresenius Vial SA, 
France) is based on adult pharmacokinetic model, and usage in 
children is limited [10]. The limitation of age and body weight for 
the TCI is 16 years-old and 30 kg respectively, and it is difficult 
to use in younger children. Our patient was only 6 years-old and 
weighted 19 kg. Therefore, it was not appropriate to use TCI. 
    Bispectral index monitoring has been developed as a tool 
for measuring the depth of anesthesia in adults, but the use 
of BIS has generated several curious findings in children. The 
nervous system is functionally immature at birth, myelination 
is rapid during the first 2 years and completed by 7 years of age. 
Therefore, BIS cannot be applied to young children. And BIS 
increases with decreasing age [11,12]. Age itself is considered to 
be a factor affecting BIS values. 
    But some studies showed the validity of BIS in children older 
than 2 years [13-15]. Monitoring with BIS, not absolute value 
but trend is more important. BIS is the most valid monitor to 
measuring the depth of anesthesia to date.161 www.ekja.org
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    In conclusion, we recommend anesthetists to pay close atten-
tion to the neurophysiologic and neuromuscular monitoring for 
patients with Duchenne muscular dystrophic.
References
1. Shin HH, Park DH, Lee C, Woo SC, Kim YJ, Joo JH, et al. Anesthesia 
for a 10-year-old boy with Duchenne muscular dystrophy syndrome: 
A case report. Korean J Anesthesiol 2008; 55: 217-20.
2. Frankowski GA, Johnson JO, Tobias JD. Rapacuronium administ-
ration to two children with Duchenne's muscular dystrophy. Anesth 
Analg 2000; 91: 27-8.
3. Uslu M, Mellinghoff H, Diefenbach C. Mivacurium for muscle 
relaxation in a child with Duchenne's muscular dystrophy. Anesth 
Analg 1999; 89: 340-1.
4. Atlas G, Patel A. Pediatric-compatible train-of-four monitoring. 
Paediatr Anaesth 2005; 15: 707-8.
5. Tobias JD, Lynch A, McDuffee A, Garrett JS. Pancuronium infusion 
for neuromuscular block in children in the pediatric intensive care 
unit. Anesth Analg 1995; 81: 13-6.
6. Rodiera J, Serradell A, Alvarez-Gómez JA, Aliaga L. The cuff method: 
a pilot study of a new method of monitoring neuromuscular 
function. Acta Anaesthesiol Scand 2005; 49: 1552-8.
7. Withington D, Menard G, Varin F. Cisatracurium pharmacokinetics 
and pharmacodynamics during hypothermic cardiopulmonary 
bypass in infants and children. Paediatr Anaesth 2011; 21: 341-6. 
8. Aun CS, Short SM, Leung DH, Oh TE. Induction dose-response of 
propofol in unpremedicated children. Br J Anaesth 1992; 68: 64-7.
9. Marsh B, White M, Morton N, Kenny GN. Pharmacokinetic model 
driven infusion of propofol in children. Br J Anaesth 1991; 67: 41-8.
10. Han JI, Lee HS. Is it safe to use target-controlled propofol infusion 
with Diprifusor
TM for children for school age? Korean J Anesthesiol 
2004; 47: 667-70.
11. Oh AY, Gil NS, Yoon SJ, Kim HS, Kim SD, Kim CS. The differences in 
bispectral index according to age during sevoflurane anesthesia in 
children aged 1-7 years. Korean J Anesthesiol 2004; 47: 635-8.
12. Lerman J. Inhalation agents in pediatric anaesthesia - an update. 
Curr Opin Anaesthesiol 2007; 20: 221-6.
13. Degoute CS, Macabeo C, Dubreuil C, Duclaux R, Banssillon V. EEG 
bispectral index and hypnotic component of anaesthesia induced 
by sevoflurane: comparison between children and adults. Br J 
Anaesth 2001; 86: 209-12.
14. Davidson AJ, McCann ME, Devavaram P, Auble SA, Sullivan LJ, 
Gillis JM, et al. The differences in the bispectral index between 
infants and children during emergence from anesthesia after 
circumcision surgery. Anesth Analg 2001; 93: 326-30.
15. Bannister CF, Brosius KK, Sigl JC, Meyer BJ, Sebel PS. The effect 
of bispectral index monitoring on anesthetic use and recovery in 
children anesthetized with sevoflurane in nitrous oxide. Anesth 
Analg 2001; 92: 877-81.